160 related articles for article (PubMed ID: 8813534)
1. Ipsapirone enhances the dopamine outflow via 5-HT1A receptors in the rat prefrontal cortex.
Wedzony K; Maćkowiak M; Fijał K; Gołembiowska K
Eur J Pharmacol; 1996 Jun; 305(1-3):73-8. PubMed ID: 8813534
[TBL] [Abstract][Full Text] [Related]
2. Evidence that conditioned stress enhances outflow of dopamine in rat prefrontal cortex: a search for the influence of diazepam and 5-HT1A agonists.
Wedzony K; Maćkowiak M; Fijał K; Gołembiowska K
Synapse; 1996 Nov; 24(3):240-7. PubMed ID: 8923664
[TBL] [Abstract][Full Text] [Related]
3. Effect of acute administration of the 5-HT1A receptor ligand, lesopitron, on rat cortical 5-HT and dopamine turnover.
Ballarín M; Carceller A; Guitart X
Br J Pharmacol; 1994 Oct; 113(2):425-30. PubMed ID: 7530571
[TBL] [Abstract][Full Text] [Related]
4. The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons.
Mos J; Van Hest A; Van Drimmelen M; Herremans AH; Olivier B
Eur J Pharmacol; 1997 May; 325(2-3):145-53. PubMed ID: 9163561
[TBL] [Abstract][Full Text] [Related]
5. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635.
de Boer SF; Lesourd M; Mocaer E; Koolhaas JM
J Pharmacol Exp Ther; 1999 Mar; 288(3):1125-33. PubMed ID: 10027850
[TBL] [Abstract][Full Text] [Related]
6. Postsynaptic 5-hydroxytryptamine(1A) receptor activation increases in vivo dopamine release in rat prefrontal cortex.
Sakaue M; Somboonthum P; Nishihara B; Koyama Y; Hashimoto H; Baba A; Matsuda T
Br J Pharmacol; 2000 Mar; 129(5):1028-34. PubMed ID: 10696105
[TBL] [Abstract][Full Text] [Related]
7. Effect of repeated ipsapirone treatment on hippocampal excitatory synaptic transmission in the freely behaving rat: role of 5-HT1A receptors and relationship to anxiolytic effect.
Xu L; Anwyl R; De Vry J; Rowan MJ
Eur J Pharmacol; 1997 Mar; 323(1):59-68. PubMed ID: 9105877
[TBL] [Abstract][Full Text] [Related]
8. Buspirone modulates basal and fluoxetine-stimulated dialysate levels of dopamine, noradrenaline and serotonin in the frontal cortex of freely moving rats: activation of serotonin1A receptors and blockade of alpha2-adrenergic receptors underlie its actions.
Gobert A; Rivet JM; Cistarelli L; Melon C; Millan MJ
Neuroscience; 1999; 93(4):1251-62. PubMed ID: 10501449
[TBL] [Abstract][Full Text] [Related]
9. In-vivo effects of the 1,2,4-piperazine derivatives MM5 and MC1, putative 5-HT agonists, on dopamine and serotonin release in rat prefrontal cortex.
Iskra-Jopa J; Gołembiowska K; Dziubina A; Cybulski M; Duszyńska B; Chilmonczyk Z
J Pharm Pharmacol; 2005 Feb; 57(2):205-11. PubMed ID: 15720784
[TBL] [Abstract][Full Text] [Related]
10. Neurotrophic effects of ipsapirone and other 5-HT1A receptor agonists on septal cholinergic neurons in culture.
Riad M; Emerit MB; Hamon M
Brain Res Dev Brain Res; 1994 Oct; 82(1-2):245-58. PubMed ID: 7842512
[TBL] [Abstract][Full Text] [Related]
11. F 11440, a potent, selective, high efficacy 5-HT1A receptor agonist with marked anxiolytic and antidepressant potential.
Koek W; Patoiseau JF; Assié MB; Cosi C; Kleven MS; Dupont-Passelaigue E; Carilla-Durand E; Palmier C; Valentin JP; John G; Pauwels PJ; Tarayre JP; Colpaert FC
J Pharmacol Exp Ther; 1998 Oct; 287(1):266-83. PubMed ID: 9765347
[TBL] [Abstract][Full Text] [Related]
12. Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies.
Schechter LE; Bolaños FJ; Gozlan H; Lanfumey L; Haj-Dahmane S; Laporte AM; Fattaccini CM; Hamon M
J Pharmacol Exp Ther; 1990 Dec; 255(3):1335-47. PubMed ID: 1702155
[TBL] [Abstract][Full Text] [Related]
13. The role of postsynaptic 5-HT1A receptors in the anticonflict effect of ipsapirone.
Przegaliński E; Tatarczyńska E; Kłodzińska A; Chojnacka-Wójcik E
Neuropharmacology; 1994 Sep; 33(9):1109-15. PubMed ID: 7838324
[TBL] [Abstract][Full Text] [Related]
14. Enhancement by ipsapirone of dopamine release in the rat striatum.
Gołembiowska K; Wedzony K
Pol J Pharmacol; 1993; 45(3):299-308. PubMed ID: 7693136
[TBL] [Abstract][Full Text] [Related]
15. Effects of MP-3022 on the 8-OH-DPAT-induced discriminative stimulus in rats.
Filip M; Przegaliński E
Pol J Pharmacol; 1996; 48(4):397-402. PubMed ID: 9112679
[TBL] [Abstract][Full Text] [Related]
16. Effects of acute and chronic buspirone on impulsive choice and efflux of 5-HT and dopamine in hippocampus, nucleus accumbens and prefrontal cortex.
Liu YP; Wilkinson LS; Robbins TW
Psychopharmacology (Berl); 2004 Apr; 173(1-2):175-85. PubMed ID: 14726995
[TBL] [Abstract][Full Text] [Related]
17. Neuronal circuits involved in the anxiolytic effects of the 5-HT1A receptor agonists 8-OH-DPAT ipsapirone and buspirone in the rat.
Schreiber R; De Vry J
Eur J Pharmacol; 1993 Nov; 249(3):341-51. PubMed ID: 7904566
[TBL] [Abstract][Full Text] [Related]
18. Tandospirone potentiates the fluoxetine-induced increases in extracellular dopamine via 5-HT(1A) receptors in the rat medial frontal cortex.
Yoshino T; Nisijima K; Katoh S; Yui K; Nakamura M
Neurochem Int; 2002 Apr; 40(4):355-60. PubMed ID: 11792466
[TBL] [Abstract][Full Text] [Related]
19. Valproate and carbamazepine increase prefrontal dopamine release by 5-HT1A receptor activation.
Ichikawa J; Meltzer HY
Eur J Pharmacol; 1999 Sep; 380(1):R1-3. PubMed ID: 10513560
[TBL] [Abstract][Full Text] [Related]
20. Anxiolytic 5-hydroxytryptamine1A agonists suppress firing activity of dorsal hippocampus CA1 pyramidal neurons through a postsynaptic mechanism: single-unit study in unanesthetized, unrestrained rats.
Tada K; Kasamo K; Ueda N; Suzuki T; Kojima T; Ishikawa K
J Pharmacol Exp Ther; 1999 Feb; 288(2):843-8. PubMed ID: 9918598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
